Healthcare provider profile · identity verified

Brian S Waggoner, MD

Internal Medicine · COOKEVILLE, TN · NPI 1255331914

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Prednisone	Prednisone	477	244
Atorvastatin Calcium	Atorvastatin Calcium	464	145
Gabapentin	Gabapentin	408	90
Alprazolam	Alprazolam	393	45
Rosuvastatin Calcium	Rosuvastatin Calcium	381	106
Levothyroxine Sodium	Levothyroxine Sodium	380	103
Tramadol Hcl	Tramadol Hcl	374	77
Omeprazole	Omeprazole	362	108
Pantoprazole Sodium	Pantoprazole Sodium	292	79
Quetiapine Fumarate	Quetiapine Fumarate	276	77
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	251	172
Metformin Hcl	Metformin Hcl	218	59
Trazodone Hcl	Trazodone Hcl	218	76
Metoprolol Tartrate	Metoprolol Tartrate	215	66
Tamsulosin Hcl	Tamsulosin Hcl	211	70
Carvedilol	Carvedilol	209	60
Lisinopril	Lisinopril	204	62
Dexamethasone	Dexamethasone	189	137
Amlodipine Besylate	Amlodipine Besylate	167	54
Potassium Chloride	Potassium Chloride	160	51
Eliquis	Apixaban	156	36
Furosemide	Furosemide	145	45
Losartan Potassium	Losartan Potassium	134	43
Pioglitazone Hcl	Pioglitazone Hcl	131	36
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	128	37
Metoprolol Succinate	Metoprolol Succinate	117	44
Duloxetine Hcl	Duloxetine Hcl	114	41
Simvastatin	Simvastatin	109	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	105	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	104	19
Fluconazole	Fluconazole	102	50
Bumetanide	Bumetanide	98	33
Spironolactone	Spironolactone	97	38
Pregabalin	Pregabalin	96	25
Cefdinir	Cefdinir	95	72
Acetaminophen-Codeine	Acetaminophen With Codeine	94	22
Aripiprazole	Aripiprazole	94	32
Hydrochlorothiazide	Hydrochlorothiazide	94	28
Clonazepam	Clonazepam	93	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	92	65
Doxycycline Hyclate	Doxycycline Hyclate	90	57
Meloxicam	Meloxicam	90	36
Citalopram Hbr	Citalopram Hydrobromide	88	22
Pravastatin Sodium	Pravastatin Sodium	88	28
Clopidogrel	Clopidogrel Bisulfate	85	23
Ozempic	Semaglutide	83	21
Allopurinol	Allopurinol	81	25
Felodipine Er	Felodipine	79	31
Mirtazapine	Mirtazapine	79	29
Olmesartan Medoxomil	Olmesartan Medoxomil	78	21
Verapamil Er	Verapamil Hcl	78	28
Sertraline Hcl	Sertraline Hcl	76	23
Esomeprazole Magnesium	Esomeprazole Magnesium	75	22
Azithromycin	Azithromycin	74	64
Bupropion Xl	Bupropion Hcl	74	26
Glimepiride	Glimepiride	73	22
Diclofenac Sodium	Diclofenac Sodium	70	25
Ondansetron Hcl	Ondansetron Hcl	70	26
Temazepam	Temazepam	69	12
Xarelto	Rivaroxaban	69	20
Fluticasone Propionate	Fluticasone Propionate	68	29
Lorazepam	Lorazepam	63	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	62	22
Doxazosin Mesylate	Doxazosin Mesylate	61	19
Ezetimibe	Ezetimibe	61	20
Venlafaxine Hcl Er	Venlafaxine Hcl	61	15
Albuterol Sulfate Hfa	Albuterol Sulfate	58	20
Nifedipine Er	Nifedipine	58	16
Nortriptyline Hcl	Nortriptyline Hcl	57	23
Zolpidem Tartrate	Zolpidem Tartrate	57	12
Montelukast Sodium	Montelukast Sodium	53	13
Escitalopram Oxalate	Escitalopram Oxalate	52	20
Mounjaro	Tirzepatide	50	11
Clonidine Hcl	Clonidine Hcl	49	11
Testosterone Cypionate	Testosterone Cypionate	49	14
Atenolol	Atenolol	46	14
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	45	11
Alendronate Sodium	Alendronate Sodium	44	11
Diazepam	Diazepam	44	12
Fluoxetine Hcl	Fluoxetine Hcl	43	15
Olanzapine	Olanzapine	43	15
Cephalexin	Cephalexin	41	32
Jardiance	Empagliflozin	41	12
Estradiol	Estradiol	40	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	40	15
Oxybutynin Chloride	Oxybutynin Chloride	39	19
Warfarin Sodium	Warfarin Sodium	39	suppressed
Benazepril Hcl	Benazepril Hcl	38	11
Levetiracetam	Levetiracetam	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Celecoxib	Celecoxib	37	14
Farxiga	Dapagliflozin Propanediol	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	12
Propranolol Hcl	Propranolol Hcl	37	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Famotidine	Famotidine	36	11
Finasteride	Finasteride	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Risperidone	Risperidone	35	12
Lovastatin	Lovastatin	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	12
Baclofen	Baclofen	33	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Doxepin Hcl	Doxepin Hcl	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Klor-Con M20	Potassium Chloride	31	suppressed
Labetalol Hcl	Labetalol Hcl	30	suppressed
Myrbetriq	Mirabegron	29	12
Methotrexate	Methotrexate Sodium	28	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	26	15
Eszopiclone	Eszopiclone	26	suppressed
Terbinafine Hcl	Terbinafine Hcl	26	20
Topiramate	Topiramate	26	suppressed
Fluocinonide	Fluocinonide	25	14
Leflunomide	Leflunomide	25	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Levofloxacin	Levofloxacin	24	17
Donepezil Hcl	Donepezil Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	11
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Glipizide	Glipizide	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Chlorthalidone	Chlorthalidone	17	suppressed
Linzess	Linaclotide	17	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Atrovent Hfa	Ipratropium Bromide	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Verapamil Sr	Verapamil Hcl	16	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Colchicine	Colchicine	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error